Join
Live feed
·
INSIDERFilingvia Quantisnow
Beam Therapeutics Inc. logo

Chief Financial Officer Emany Sravan Kumar sold $170,567 worth of shares (6,294 units at $27.10), decreasing direct ownership by 8% to 73,706 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BEAM· Beam Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BEAM (Beam Therapeutics Inc.) and more on Quantisnow.